TrialHaematologica2019

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.

John R Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.